Paramagnetic Contrast Agent
- Name
- Paramagnetic Contrast Agent
- Accession Number
- DBCAT003301
- Description
Not Available
- Drugs
Drug Drug Description Mangafodipir An organ-specific paramagnetic contrast agent indicated for the imaging of the hepatobiliary system and detecting lesions in the liver and pancreas. Gadodiamide A gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity. Gadoversetamide A gadolinium compound used as a contrast agent in MRI tests of the brain, spine, and liver. Gadoteridol A gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity. Gadobenic acid A gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity. Gadopentetic acid A gadolinium compound used as a contrast agent in MRIs. Ferumoxytol An intravenous iron replacement product used to treat iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD), or in patients who are unable to tolerate or who have not responded adequately to oral iron supplementation. Gadofosveset trisodium An intravenous contrast agent used during magnetic resonance angiography (MRA) to evaluate aortoiliac occlusive disease (AIOD) in adults with peripheral vascular disease. Manganese A transition metal used for supplementation of manganese during Total Parenteral Nutrition (TPN). Gadoxetic acid A gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize the liver. Gadopiclenol A gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity. - Drugs & Drug Targets